| Schedule of Segment Information |
The following table summarizes certain information regarding segments of the Company's continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
| (in thousands) |
2024 |
|
2023 |
|
|
|
|
|
|
|
|
| Net sales |
|
|
|
|
|
|
|
|
|
|
|
| Tubular Products |
$ |
23,814 |
|
|
$ |
31,061 |
|
|
|
|
|
|
|
|
|
| Specialty Chemicals |
20,296 |
|
|
23,749 |
|
|
|
|
|
|
|
|
|
| All Other |
— |
|
|
50 |
|
|
|
|
|
|
|
|
|
|
$ |
44,110 |
|
|
$ |
54,860 |
|
|
|
|
|
|
|
|
|
| Operating (loss) income |
|
|
|
|
|
|
|
|
|
|
|
| Tubular Products |
$ |
(1,502) |
|
|
$ |
(3,293) |
|
|
|
|
|
|
|
|
|
| Specialty Chemicals |
(1,439) |
|
|
1,352 |
|
|
|
|
|
|
|
|
|
| All Other |
(162) |
|
|
(479) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Corporate |
|
|
|
|
|
|
|
|
|
|
|
| Unallocated corporate expenses |
(2,150) |
|
|
(3,704) |
|
|
|
|
|
|
|
|
|
| Acquisition costs and other |
— |
|
|
(259) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Corporate |
(2,150) |
|
|
(3,963) |
|
|
|
|
|
|
|
|
|
| Operating loss |
(5,253) |
|
|
(6,383) |
|
|
|
|
|
|
|
|
|
| Interest expense |
127 |
|
|
1,107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other, net |
(120) |
|
|
(95) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss from continuing operations before income taxes |
$ |
(5,260) |
|
|
$ |
(7,395) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
|
|
|
|
| (in thousands) |
March 31, 2024 |
|
December 31, 2023 |
|
|
|
|
|
|
|
|
| Identifiable assets |
|
|
|
|
|
|
|
|
|
|
|
| Tubular Products |
$ |
72,668 |
|
|
$ |
70,548 |
|
|
|
|
|
|
|
|
|
| Specialty Chemicals |
46,391 |
|
|
49,547 |
|
|
|
|
|
|
|
|
|
| Corporate and other |
41,866 |
|
|
42,339 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
160,925 |
|
|
$ |
162,434 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|